COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $379,318 | -15.6% | 101,422 | -3.7% | 0.00% | – |
Q2 2023 | $449,669 | -39.0% | 105,309 | -2.3% | 0.00% | – |
Q1 2023 | $737,270 | -16.0% | 107,788 | -2.7% | 0.00% | – |
Q4 2022 | $877,813 | -15.8% | 110,835 | +2.2% | 0.00% | – |
Q3 2022 | $1,043,000 | +31.5% | 108,488 | -0.9% | 0.00% | – |
Q2 2022 | $793,000 | -43.6% | 109,476 | +0.5% | 0.00% | – |
Q1 2022 | $1,406,000 | -18.3% | 108,924 | +1.0% | 0.00% | – |
Q4 2021 | $1,721,000 | -2.6% | 107,804 | -2.0% | 0.00% | -100.0% |
Q3 2021 | $1,767,000 | +14.7% | 109,987 | -1.3% | 0.00% | – |
Q2 2021 | $1,541,000 | -4.5% | 111,431 | +0.9% | 0.00% | – |
Q1 2021 | $1,614,000 | -24.9% | 110,475 | -10.6% | 0.00% | -100.0% |
Q4 2020 | $2,148,000 | -6.2% | 123,567 | -1.0% | 0.00% | 0.0% |
Q3 2020 | $2,289,000 | -1.2% | 124,804 | -3.8% | 0.00% | 0.0% |
Q2 2020 | $2,316,000 | +7.4% | 129,693 | -2.5% | 0.00% | 0.0% |
Q1 2020 | $2,157,000 | +7.0% | 132,999 | +18.8% | 0.00% | 0.0% |
Q4 2019 | $2,016,000 | +477.7% | 111,949 | +550.3% | 0.00% | – |
Q3 2019 | $349,000 | – | 17,216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |